348 related articles for article (PubMed ID: 27404875)
21. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
[TBL] [Abstract][Full Text] [Related]
22. Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures.
Ang PS; Chen Z; Chan CL; Tai BC
Expert Opin Drug Saf; 2016 May; 15(5):583-90. PubMed ID: 26996192
[TBL] [Abstract][Full Text] [Related]
23. Development of a personal electronic health record card in the United Kingdom.
Rybynok VO; Kyriacou PA; Binnersley J; Woodcock A
Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():4431-5. PubMed ID: 21095764
[TBL] [Abstract][Full Text] [Related]
24. Disproportionality Analysis Used to Identify Patterns in Medication Error Reports Involving Hospitalized Children.
Rishoej RM; Thybo Christesen H; Juel Kjeldsen L; Almarsdóttir AB; Hallas J
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):531-533. PubMed ID: 29265731
[No Abstract] [Full Text] [Related]
25. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERS.
Ando G; Taguchi K; Enoki Y; Yokoyama Y; Kizu J; Matsumoto K
Biol Pharm Bull; 2019; 42(11):1799-1804. PubMed ID: 31685764
[TBL] [Abstract][Full Text] [Related]
27. Extraction Of Adverse Events From Clinical Documents To Support Decision Making Using Semantic Preprocessing.
Gaebel J; Kolter T; Arlt F; Denecke K
Stud Health Technol Inform; 2015; 216():1030. PubMed ID: 26262330
[TBL] [Abstract][Full Text] [Related]
28. Detecting software failures in the MAUDE database: a preliminary analysis.
Pecoraro F; Luzi D
Stud Health Technol Inform; 2013; 192():1098. PubMed ID: 23920872
[TBL] [Abstract][Full Text] [Related]
29. Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use.
Li AS; Pomeranz HD
J Neuroophthalmol; 2016 Dec; 36(4):480-481. PubMed ID: 27851718
[No Abstract] [Full Text] [Related]
30. Exploring the FDA adverse event reporting system to generate hypotheses for monitoring of disease characteristics.
Fang H; Su Z; Wang Y; Miller A; Liu Z; Howard PC; Tong W; Lin SM
Clin Pharmacol Ther; 2014 May; 95(5):496-8. PubMed ID: 24448476
[TBL] [Abstract][Full Text] [Related]
31. The class imbalance problem detecting adverse drug reactions in electronic health records.
Santiso S; Casillas A; Pérez A
Health Informatics J; 2019 Dec; 25(4):1768-1778. PubMed ID: 30230408
[TBL] [Abstract][Full Text] [Related]
32. Illusions of objectivity and a recommendation for reporting data mining results.
Hauben M; Reich L; Gerrits CM; Younus M
Eur J Clin Pharmacol; 2007 May; 63(5):517-21. PubMed ID: 17364192
[TBL] [Abstract][Full Text] [Related]
33. Signal detection in FDA AERS database using Dirichlet process.
Hu N; Huang L; Tiwari RC
Stat Med; 2015 Aug; 34(19):2725-42. PubMed ID: 25924820
[TBL] [Abstract][Full Text] [Related]
34. First experiences in implementing a software-based support for patient recruitment at Heidelberg university hospital.
Schreiweis B; Grüber G; Bergh B
Stud Health Technol Inform; 2012; 180():1147-9. PubMed ID: 22874382
[TBL] [Abstract][Full Text] [Related]
35. Extraction of adverse drug effects from clinical records.
Aramaki E; Miura Y; Tonoike M; Ohkuma T; Masuichi H; Waki K; Ohe K
Stud Health Technol Inform; 2010; 160(Pt 1):739-43. PubMed ID: 20841784
[TBL] [Abstract][Full Text] [Related]
36. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy.
Wang X; Zhang P; Chiang CW; Wu H; Shen L; Ning X; Zeng D; Wang L; Quinney SK; Feng W; Li L
Stat Med; 2018 Feb; 37(4):673-686. PubMed ID: 29171062
[TBL] [Abstract][Full Text] [Related]
37. Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).
Wei L; Scott J
Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):922-33. PubMed ID: 26045284
[TBL] [Abstract][Full Text] [Related]
38. More eyeballs on AERS.
Pratt LA; Danese PN
Nat Biotechnol; 2009 Jul; 27(7):601-2. PubMed ID: 19587659
[No Abstract] [Full Text] [Related]
39. Hazards of hindsight--monitoring the safety of nutritional supplements.
Cohen PA
N Engl J Med; 2014 Apr; 370(14):1277-80. PubMed ID: 24693886
[No Abstract] [Full Text] [Related]
40. Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants.
Wong CK; Ho SS; Saini B; Hibbs DE; Fois RA
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):731-7. PubMed ID: 26017154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
